Histological changes associated with the use of intravenous cyclosporin in the treatment of severe ulcerative colitis may mimic dysplasia

Colorectal Disease

Volumn 4, Issue 6, 2002, Pages 455-458

  Hyde, G M ^a   Jewell, D P ^a   Warren, B F ^a  

^a JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

Cyclosporin; Dysplasia; Ulcerative colitis

Indexed keywords

CYCLOSPORIN; STEROID;

ADULT; ARTICLE; AWARENESS; CLINICAL ARTICLE; COLON BIOPSY; COLON MUCOSA; COLON RESECTION; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG USE; DYSPLASIA; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE VILLUS; MALE; MEDICAL ASSESSMENT; PATIENT CARE; PREOPERATIVE PERIOD; PRIORITY JOURNAL; SCORING SYSTEM; TISSUE REGENERATION; TISSUE SECTION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

EID: 0036847964     PISSN: 14628910     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1463-1318.2002.00392.x     Document Type: Article

References (14)

1. Baker K, Jewell DP. Cyclosporin for the treatment of severe inflammatory bowel disease. Alimentary Pharmacol Ther 1989; 3: 143-9.
2. Lichtiger S. Cyclosporin therapy in inflammatory bowel disease: open label experience. Mt Sinai J Med 1990; 57: 315-9.
3. Lichtiger S, Present DH, Kornbluth A, Gelernt I. Cyclosporin in severe ulcerative colitis refractory to steroid therapy. New Eng J Med 1994; 330: 1841-5.
4. Hyde GM, Thillainayagam AV, Jewell DP. Intravenous Cyclosporin as rescue therapy in acute, severe Ulcerative Colitis, time for a reappraisal? Europ J Gastroenterol Hepatol 1998; 10: 411-3.
5. Shah KA, Shurey S, Green CJ. Cyclosporin in ischaemia-reperfusion injury: Partial protection to isotransplanted small bowel mucosa. J Pathol 1998; 184: 19A.
6. Truelove S, Witts D. Final report on a therapeutic trial. Br Med J 1955; 2: 1041-8.
7. Noffsinger AE, Miller MA, Cusi MV, Fenoglio-Preiser CM. The Pattern of cell proliferation in neoplastic and non-neoplastic lesions of ulcerative colitis. Cancer 1996; 78: 2307-12.
8. Noffsinger AE, Belli JM, Miller MA, Fenoglio-Preiser CM. A unique basal pattern of p53 expression in ulcerative colitis is associated with mutation in the p53 gene. Histopathology 2001; 39: 482-92.
9. Kurokawa T, Kobayashi H, Nonami T et al. Beneficial effects of cyclosporin on post ischaemic liver injury in rats. Transplantation 1992; 53: 308-11.
10. Yamanoi A, Nagasue N, Kohno H, Chang Y et al. Attenuation of ischaemia-reperfusion injury of the liver in dogs by cyclosporin. Transplantation 1991; 52: 27-30.
11. Goto S, Kim Y, Shimada T, Kawano K, Kobayashi M. The effects of pretransplant cyclosporin therapy on rats grafted with twelve-hour cold-stored livers-with special reference to reperfusion injury. Transplantation 1991; 52: 615-21.
12. Wakita H, Tomimoto H, Akiguchi I, Kimura J. Protective effect of Cyclosporin A on white matter changes in the rat brain after chronic cerebral hypoperfusion. Stroke 1995; 26: 1415-22.
13. Puglisi RN, Strande L, Santos M, Doolin EJ et al. The effect of Cyclosporin in gut ischaemic injury: a computerised morphometric and enzymatic analysis. J Paediatric Surg 1996; 31: 319-22.
14. Kim Y, Calne RY. Cyclosporin A stimulates proliferation of the liver cells after partial hepatectomy in rats. Surgery Gynae Obstet 1988; 166: 317-22.